MRK vs QTTB · P/E 33, rev $16.61B vs rev $53.7M
Merck & Company Inc (MRK) versus Q32 Bio Inc (QTTB) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Q32 Bio Inc (QTTB) is a biotechnology company listed on US.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported QTTB revenue for 2025-12-31 was $53.7M. Net income was $29.8M. QTTB currently screens at market cap $32.4M.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. QTTB currently screens at market cap $32.4M.
Not investment advice. Open the MRK and QTTB stock pages for the full models.
Not investment advice.